Cardiff Oncology Inc (FRA:XE7C) Transcripts
Q2 2024 Cardiff Oncology Inc Earnings Call Transcript
Aug 08, 2024
€1.88
(-5.54%)
Earnings
Q1 2024 Cardiff Oncology Inc Earnings Call Transcript
May 02, 2024
€3.87
(-5.39%)
Earnings
Q4 2023 Cardiff Oncology Inc Earnings Call Transcript
Feb 29, 2024
€1.64
(+2.24%)
Earnings
Q3 2023 Cardiff Oncology Inc Earnings Call Transcript
Nov 02, 2023
€1.01
(+2.44%)
Earnings
Cardiff Oncology Inc Clinical Update Call Transcript
Sep 26, 2023
Cardiff Oncology Inc Clinical and Corporate Update Call Transcript
Aug 07, 2023
Cardiff Oncology Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023
Cardiff Oncology Inc at Cowen Health Care Conference- GI/GU Oncology Panel Transcript
Mar 07, 2023
Cardiff Oncology Inc at JMP Securities Hematology Oncology Summit (Virtual) Transcript
Dec 07, 2022
Cardiff Oncology Inc at Piper Sandler Healthcare Conference Transcript
Nov 29, 2022
Cardiff Oncology Inc to Provide a Clinical and Corporate Update Call Transcript
Sep 12, 2022
Cardiff Oncology Inc to Discuss Updated Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer at ASCO-GI Transcript
Jan 18, 2022
Cardiff Oncology Inc to Discuss New Data from Lead Clinical Program in KRAS-mutated mCRC Webinar Transcript
Sep 08, 2021
Cardiff Oncology Inc at William Blair Biotech Focus Conference (Virtual) Transcript
Jul 15, 2021
Cardiff Oncology Inc KOL Webinar Transcript
Apr 12, 2021
Cardiff Oncology Inc Discusses KRAS Mutations in Cancer Transcript
Oct 14, 2020
Cardiff Oncology, Inc. - Special Call Transcript
Sep 23, 2020
Cardiff Oncology Inc Onvansertib Clinical Trials Transcript
May 18, 2020
Trovagene Inc at Needham Healthcare Conference Transcript
Apr 15, 2020
Trovagene Inc Business Update Conference Call Transcript
Jun 07, 2019